DOUGLAS RHODA: Open Payments
NPI 1760494603 · MILLINOCKET, ME. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,690 in 81 payments from 15 companies in 2025. Trend: 2023 $3,853 · 2024 $1,781 · 2025 $1,690
Food & beverage: $1,521Education: $168
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. | 25 | $431 |
| ABBVIE INC. | 33 | $280 |
| UCB, Inc. | 3 | $198 |
| Janssen Biotech, Inc. | 3 | $153 |
| Regeneron Healthcare Solutions, Inc. | 2 | $108 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $103 |
| Amgen Inc. | 1 | $100 |
| Arcutis Biotherapeutics, Inc. | 1 | $83 |
| LEO Pharma Inc. | 2 | $70 |
| Novartis Pharmaceuticals Corporation | 2 | $56 |
Products named: NEMLUVIO, SKYRIZI, Bimzelx, TREMFYA, DUPIXENT, OTEZLA, Zoryve, ANZUPGO.
Industry payments across ME — which companies pay providers there.
